Physician

Harminder Singh Sethi, MD

According to 2025 Medicare claims, Harminder Sethi, MD (NPI: 1275563033) practices hematology/oncology in the Washington, DC-MD market, with the plurality of this provider's patient population coming from The District, DC. This provider's primary affiliated billing organization is MARYLAND ONCOLOGY HEMATOLOGY, P.A. (NPI: 1821271032; TIN: 113652573) and primary practice location at 20782-9998.

Sethi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 615 traditional Medicare patients, billed 194,790 HCPCS/CPT codes, and received $2,519,381 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 1,085 prescription claims across 187 beneficiaries totaling $4,009,343 in drug costs, led by Revlimid (Lenalidomide). 2020 DME data shows 34 claims. Open Payments data shows 158 records totaling $4,785. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,069,995 to $2,519,381. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $796,529 to $4,009,343. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.